Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.17 USD
597.60 M USD
3.70 B USD
189.56 M
About Incyte Corporation
Sector
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
Founded
1991
FIGI
BBG000BNPSQ9
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where INCY is featured.
Frequently Asked Questions
The current price of INCY is 68.55 USD — it has decreased by −3.22% in the past 24 hours. Watch Incyte Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Incyte Corporation stocks are traded under the ticker INCY.
INCY stock has fallen by −8.93% compared to the previous week, the month change is a −15.16% fall, over the last year Incyte Corporation has showed a 6.28% increase.
We've gathered analysts' opinions on Incyte Corporation future price: according to them, INCY price has a max estimate of 97.00 USD and a min estimate of 52.00 USD. Watch INCY chart and read a more detailed Incyte Corporation stock forecast: see what analysts think of Incyte Corporation and suggest that you do with its stocks.
INCY reached its all-time high on Mar 15, 2017 with the price of 153.15 USD, and its all-time low was 1.66 USD and was reached on Sep 22, 1994. View more price dynamics on INCY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INCY stock is 3.37% volatile and has beta coefficient of 0.92. Track Incyte Corporation stock price on the chart and check out the list of the most volatile stocks — is Incyte Corporation there?
Today Incyte Corporation has the market capitalization of 13.65 B, it has increased by 0.11% over the last week.
Yes, you can track Incyte Corporation financials in yearly and quarterly reports right on TradingView.
Incyte Corporation is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
INCY earnings for the last quarter are 1.07 USD per share, whereas the estimation was 1.05 USD resulting in a 1.79% surprise. The estimated earnings for the next quarter are 1.50 USD per share. See more details about Incyte Corporation earnings.
Incyte Corporation revenue for the last quarter amounts to 1.14 B USD, despite the estimated figure of 1.08 B USD. In the next quarter, revenue is expected to reach 1.14 B USD.
INCY net income for the last quarter is 106.46 M USD, while the quarter before that showed −444.60 M USD of net income which accounts for 123.94% change. Track more Incyte Corporation financial stats to get the full picture.
No, INCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 14, 2024, the company has 2.52 K employees. See our rating of the largest employees — is Incyte Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Incyte Corporation EBITDA is 76.18 M USD, and current EBITDA margin is 19.87%. See more stats in Incyte Corporation financial statements.
Like other stocks, INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Incyte Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Incyte Corporation technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Incyte Corporation stock shows the neutral signal. See more of Incyte Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.